Amit Bar‐Or

机构：Children's Hospital of Philadelphia, Hospital of the University of Pennsylvania, California University of Pennsylvania, Multiple Sclerosis Research Institute, Laboratoire de Psychologie et NeuroCognition, Parker Institute for Cancer Immunotherapy, Translational Therapeutics (United States), Io Therapeutics (United States), University of Pennsylvania, Philadelphia University · ORCID：0000-0001-7179-0335

发表论文 770 篇 · 总被引 49893 次 · h-index 110

代表论文

Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial (2025 · Multiple Sclerosis Journal · 被引 5)
Clinical validation of a novel in vitro diagnostic neurofilament light chain assay for the prognostication of disease activity in people with relapsing multiple sclerosis (2025 · Multiple Sclerosis Journal · 被引 5)
Spinal Cord Leptomeningeal Enhancement as a Marker of Extensive Spinal Cord Involvement in Children With MOGAD (2025 · Neurology Neuroimmunology & Neuroinflammation · 被引 2)
Pro‐Inflammatory c ‐Met + CD4 T Cells in Multiple Sclerosis (2025 · Annals of Neurology · 被引 2)
Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial (2025 · JCI Insight · 被引 1)
Altered Glutamate Homeostasis in Paramagnetic Rim Lesions of Patients with Multiple Sclerosis (2026 · medRxiv)